PSA screening and prostate cancer mortality

BACKGROUND: Physicians have speculated that prostate-specific antigen (PSA) screening may be responsible for the reduction in prostate cancer mortality observed in the late 1990s. In order to test this hypothesis, we assessed the relation between the change in prostate cancer incidence in the early...

ver descrição completa

Detalhes bibliográficos

Publicado no:	CMAJ
Principais autores:	Perron, Linda, Moore, Lynne, Bairati, Isabelle, Bernard, Paul-Marie, Meyer, François
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Canadian Medical Association 2002
Assuntos:	Research
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC99399/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11898936/
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!